false 0000724004 0000724004 2023-08-25 2023-08-25


 
--03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549   
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported): August 25, 2023
 
MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
 
 
Colorado
(State or other jurisdiction of
incorporation)
0-11740
(Commission File Number)
84-0872291
(I.R.S. Employer
Identification No.)
 
12100 West Sixth Avenue,
Lakewood, Colorado
(Address of principal executive offices)
 
80228
(Zip Code)
 
Registrant’s telephone number, including area code: 303-987-8000
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered under Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol
 
Name of each exchange on which
registered
 
         
Common Stock, no par value
 
MLAB
 
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 


 
 

 
ITEM 5.03          AMENDMENT TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR
 
On August 25, 2023, Mesa Laboratories, Inc. (“Mesa” or the “Company”) held its annual meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, as described in Item 5.07 below, the shareholders approved and adopted amended and restated articles of incorporation of the Company (the “Amended and Restated Articles of Incorporation”) to: remove the specific purposes of the Company, amend the director exculpation provisions, and make certain non-substantive amendments to eliminate provisions that are no longer necessary. Following the Annual Meeting, on August 25, 2023, the Amended and Restated Articles of Incorporation were filed with the Colorado Secretary of State and became effective.
 
The foregoing description of the Amended and Restated Articles of Incorporation is not complete and is qualified in its entirety by reference to the full text of the Amended and Restated Articles of Incorporation, a copy of which is filed as Exhibit 3.1 to the Current Report on Form 8-K and incorporated herein by reference.
 
 
ITEM 5.07          SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
As noted in Item 5.03, the Annual Meeting was held on August 25, 2023. Holders of 5,384,280 shares of Mesa’s common stock were entitled to vote, of which 5,025,340 shares were represented in person or by proxy at the Annual Meeting.
 
The certified results of the matters voted upon at the Annual Meeting, which are more fully described in the Company’s proxy statement for the Annual Meeting, are as follows:
 
Proposal 1 Election of directors
 
Each of John Sullivan, Shiraz Ladiwala, Jenny Alltoft, Shannon Hall, Tony Tripeny, and Gary Owens was elected to the board of directors of Mesa to hold office for a one-year term, until the 2024 annual meeting of shareholders.
 
                    Broker  
   
For
   
Withheld
   
Non-Votes
 
John J. Sullivan, Ph.D.
    4,707,420       46,603       271,317  
Shiraz S. Ladiwala
    4,730,097       23,926       271,317  
Jennifer S. Alltoft
    4,684,505       69,518       271,317  
Shannon M. Hall
    4,680,029       73,994       271,317  
R. Tony Tripeny
    4,729,907       24,116       271,317  
Gary M. Owens
    4,620,655       133,368       271,317  
 
Proposal 2 Ratification of the selection by our Audit Committee of Plante & Moran, PLLC to serve as the Companys independent registered public accounting firm for the fiscal year ending March 31, 2024
 
The appointment of Plante & Moran, PLLC as the Company’s independent registered public accounting firm for the year ending March 31, 2024 was approved. 
 
     
 
            Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,954,130       53,167       18,043       --  
 
Proposal 3 Approval on a non-binding basis of the compensation of Mesas named executive officers
 
The compensation of the Company’s named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis. 
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,414,163       188,692       151,168       271,317  
 
Proposal 4 Approval of an amendment to the 2021 Equity Incentive Plan
 
The amendment to the Company’s 2021 Equity Incentive Plan was approved. 
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,584,476       130,281       39,266       271,317  
 
 

 
Proposal 5 Approval and adoption of the Amended and Restated Articles of Incorporation
 
The Amended and Restated Articles of Incorporation were approved and adopted. 
 
Remove specific purposes of the Company:
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,710,882       7,690       35,451       271,317  
 
Amend director exculpation provisions:
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,706,529       12,134       35,360       271,317  
 
Non-substantive amendments:
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
4,715,053       4,095       34,875       271,317  
 
Proposal 6 Non-binding shareholder proposal regarding greenhouse gas emissions reporting
 
A shareholder’s proposal for Mesa to present Scope 1 through 3 greenhouse gas emissions was not approved.
 
                      Broker  
For
   
Against
   
Abstain
   
Non-Votes
 
1,312,711       3,319,777       121,535       271,317  
 
ITEM 9.01          FINANCIAL STATEMENTS AND EXHIBITS
 
Exhibit No.
Description
   
3.1
Amended and Restated Articles of Incorporation of Mesa Laboratories, Inc., dated as of August 25, 2023.
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DATE: August 25, 2023
     
Mesa Laboratories, Inc.
       
(Registrant)
         
         
     
BY: 
/s/ Gary M. Owens  
       
Gary M. Owens
       
President and Chief Executive Officer